Cyst Fluid Viscosity Measurement for Malignancy Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing pancreatic cyst malignancy, such as imaging and fluid analysis, face challenges in accurately differentiating between benign and malignant cysts, leading to difficulties in early detection and unnecessary surgical interventions.
Innovation Solution
Measuring the viscosity of cyst fluid under a strain rate of at least 1000 seconds^-1, with a viscosity of 1.3 centipoise (cP) or higher characterizing a cyst as malignant or potentially malignant, using a device with a chamber, control unit, and display, or a computer program product for determining malignancy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If imaging methods (CT, MRI, EUS) are used to detect and characterize pancreatic cyst lesions, then cyst location and morphology can be clearly indicated, but diagnostic accuracy remains inadequate
Solution Approach 1:
The patent replaces complex imaging systems with a simple viscosity measurement device that applies mechanical shear strain to cyst fluid. The rheological measurement system uses a controlled shear rate approach to directly measure fluid viscosity, substituting sophisticated imaging technology with a straightforward rheological assessment method that achieves superior diagnostic accuracy.
Solution Approach 2:
The patent changes the measurement parameter from structural/morphological characteristics (detected by imaging) to rheological properties (viscosity under shear strain). By measuring the fluid's viscous response to applied shear rates, the system captures functional properties of the cyst fluid that directly correlate with malignancy, achieving 80% diagnostic accuracy.
2Measurement precision
If CEA marker analysis is performed on cyst fluid, then discrimination between mucinous and non-mucinous cysts can be achieved with 77% specificity and 61% sensitivity, but accurate differentiation between pancreatic cyst types cannot be achieved
Solution Approach 1:
The patent extracts the key diagnostic information from the complex profile of cyst fluid markers by focusing solely on rheological properties. Instead of measuring multiple biochemical markers (CEA, amylase, etc.), the system isolates and measures the viscosity characteristic under shear strain, which alone provides sufficient discriminatory power for cyst type classification and malignancy detection.
Solution Approach 2:
The patent makes the viscosity measurement parameter universal for diagnosing all types of pancreatic cysts. A single rheological measurement at a specific shear rate can differentiate between serous cystadenomas, mucinous cysts, IPMNs, and pancreatic ductal adenocarcinomas, replacing the need for multiple marker-specific tests and providing a unified diagnostic approach.
3Reliability
If string-sign method is used to measure cyst fluid properties, then break length can be measured quickly, but the method lacks theoretical framework and cannot predict viscoelastic nature of cyst fluid
Solution Approach 1:
The patent performs preliminary characterization of cyst fluid by measuring viscosity at a specific shear rate threshold (1000 seconds^-1). This pre-established measurement condition serves as a diagnostic cutoff that reliably distinguishes malignant from benign cysts, providing a simple actionable criterion without requiring complex theoretical analysis of the full viscoelastic spectrum.
4Measurement precision
If relative viscosity measurement under shear flow is performed, then differentiation between benign and malignant cysts can be achieved, but the method requires capillary measurement setup and cannot be easily standardized
Solution Approach 1:
The patent employs dynamic shear strain measurement where the fluid is subjected to a controlled, time-varying shear rate. By measuring viscosity under dynamic shear conditions rather than static or equilibrium conditions, the system captures the functional rheological behavior of cyst fluid that correlates with malignancy while using a standardized, easily implementable measurement protocol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a non-invasive method with greater accuracy than existing tests, such as the string-sign test, amylase measurement, and CEA analysis, achieving at least 80% accuracy in distinguishing between mucinous and non-mucinous cysts and guiding appropriate surgical intervention.
Implementation Method 1
measuring viscosity of the fluid under a strain rate of at least 1000 seconds^-1
Data Source
AI summary
The present invention provides methods for determining malignancy in a cyst by measuring viscosity of cyst fluid while under stain. The invention further provides devices, and computer program products for determining same.